Atul
Dalakoti
Executive director of the Federation of Indian Chambers of Commerce and Industry (FICCI) in China
Atul Dalakoti is a seasoned business leader and strategist whose 48-year journey in China has made him one of the most enduring and influential bridges between India and China. With a rare blend of deep cultural understanding and extensive commercial experience, he has become a trusted advisor to multinational corporations, government agencies, and leading industry bodies seeking to navigate one of the world’s most complex bilateral landscapes.
For over two decades, Dalakoti has served as executive director of the Federation of Indian Chambers of Commerce and Industry (FICCI) in China, where he has been instrumental in strengthening commercial linkages, facilitating market intelligence, supporting business establishment, and leading high-level dialogue platforms that enhance trust and cooperation between Indian and Chinese stakeholders.
Beyond institutional engagement, Dalakoti has played a pioneering role in shaping new avenues of collaboration among emerging economies. As the founder of the BRICS Centre for Economic & Cultural Research & Services in Xiamen, he established a private-sector platform dedicated to advancing trade, investment, and cultural exchange across BRICS nations. He also serves as senior consultant to China Genertec on the development of a RMB 5 billion BRICS Innovation Base headquarters project in Xiamen.
Dalakoti’s corporate advisory portfolio spans some of India’s largest and most dynamic enterprises. As China president for the Reliance Group for a decade, he oversaw all China operations, led sourcing worth $10 billion, and secured $3 billion in financing from Chinese banks. His counsel has also shaped the global strategies of OYO—where he advised the founder and CEO for over six years—along with GMR, Binani Group, Punj Lloyd, and several other companies expanding across Asia and Africa.
A pioneer in the India–China pharmaceutical corridor, Dalakoti initiated bilateral pharma trade in 1987, obtaining regulatory approvals for more than 15 products for companies such as Cadila and Torrent. He later provided strategic guidance to Ranbaxy China during a critical phase of the company’s expansion.
Today, he continues to shape international business collaboration through a diverse portfolio of advisory and board roles. He serves as deputy director general of the China Institute of Multinational Corporations (a MOFCOM affiliate), investment promotion consultant to the Beijing Municipal Government, senior adviser to the Asia Capital Forum, and independent director of Power HF Co., Ltd., listed on the Shanghai Stock Exchange. His expertise also supports regional development zones in Nanjing and Nanchang, as well as the Global Tech Transfer Center (Hainan), a joint venture across pharma, agriculture, and software technologies.
Across nearly five decades, he has built a distinguished career defined by cultural fluency, strategic insight, and a deep commitment to fostering cooperation between India, China, and the wider global community—earning him recognition as one of the most enduring advocates for economic and cultural synergy between the two nations.